101 related articles for article (PubMed ID: 1881558)
1. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
Canonico V; Ammaturo V; Guarini P; Tedeschi C; Nunziata G; Nappi A; Forgione L; Rengo F
Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
[TBL] [Abstract][Full Text] [Related]
2. [Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
Craveri A; Colombo L; Cristina M; Coloru M; De Angeli B; Lanfredini M
Clin Ter; 1991 Jan; 136(1):23-9. PubMed ID: 1826869
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of picotamide in long-term treatment of intermittent claudication.
Coto V; Cocozza M; Oliviero U; Lucariello A; Picano T; Coto F; Cacciatore L
Angiology; 1989 Oct; 40(10):880-5. PubMed ID: 2679241
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation at midterm of the clinico-instrumental efficacy and tolerance of picotamide in patients with obliterative arteriopathy of the lower limbs].
Guarini P; Canonico V; Tedeschi C; Cristiano C; De Fortuna EM; Messina V; Aliperta A
Minerva Cardioangiol; 1989 Dec; 37(12):517-9. PubMed ID: 2622539
[TBL] [Abstract][Full Text] [Related]
5. [Picotamide: use in chronic obliterative arteriopathies of the lower limbs].
Tazza G; Tazza R; Valentini M; Leoni G; Avenia N; Ragusa M
Clin Ter; 1991 Jun; 137(6):399-402. PubMed ID: 1832611
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of arteriolar reactivity and blood coagulation parameters during picotamide treatment].
Saitta A; Bonaiuto M; Mileto A
Clin Ter; 1991 Oct 15-31; 139(1-2):9-16. PubMed ID: 1837769
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
Neirotti M; Molaschi M; Ponzetto M; Macchione C; Poli L; Bonino F; Fabris F
Angiology; 1994 Feb; 45(2):137-41. PubMed ID: 8129189
[TBL] [Abstract][Full Text] [Related]
8. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
Rossini A; Tascino C; Costa F
Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
[TBL] [Abstract][Full Text] [Related]
9. [Picotamide: prevention and therapy of diabetic vasculopathies. A double-blind clinical study].
Pibiri L; Petruzzo P; De Giudici A; Brotzu G
Clin Ter; 1990 May; 133(4):233-7. PubMed ID: 2142911
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of picotamide in patients with vascular diseases].
Speziale F; Taurino M; Colella E; Rizzo L; Fiorani P
Recenti Prog Med; 1989 May; 80(5):271-5. PubMed ID: 2762664
[TBL] [Abstract][Full Text] [Related]
11. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
12. Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
Milani M; Longoni A; Maderna M
Br J Clin Pharmacol; 1996 Dec; 42(6):782-5. PubMed ID: 8971437
[TBL] [Abstract][Full Text] [Related]
13. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A
Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
[TBL] [Abstract][Full Text] [Related]
14. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
[TBL] [Abstract][Full Text] [Related]
15. Antiaggregatory effects of picotamide in long-term treatment: a 2-year, double-blind placebo-controlled trial.
Cocozza M; Milani M; Picano T; Oliviero U; Russo N; Coto V
Vasc Med; 1997 Nov; 2(4):292-5. PubMed ID: 9575601
[TBL] [Abstract][Full Text] [Related]
16. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
Neri Serneri GG; Coccheri S; Marubini E; Violi F;
Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term administration of picotamide on baseline and exercise-induced urinary albumin excretion in patients with type II diabetes mellitus and incipient nephropathy.
Giustina A; Ianniello P; Bossoni S; Comini MT; Desenzani P; Gazzoli N; Romanelli G
Clin Ther; 1994; 16(2):191-9. PubMed ID: 8062315
[TBL] [Abstract][Full Text] [Related]
18. Double-blind controlled study of the efficacy and pharmacological properties of heparan sulfate in patients with occlusive arterial disease of the lower limbs.
Strano A; Pinto A; Galati D
Drugs Exp Clin Res; 1990; 16(10):543-50. PubMed ID: 2151628
[TBL] [Abstract][Full Text] [Related]
19. [Antiplatelet activity of picotamide in patients with chronic vascular pathology].
Coto V; Carrieri P; Cocozza M; Oliviero U; Picano T; Spinoli G; Cacciatore L
Minerva Cardioangiol; 1986 Sep; 34(9):601-4. PubMed ID: 2949164
[No Abstract] [Full Text] [Related]
20. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
Fonseca V; Mikhailidis DP; Barradas MA; Jeremy JY; Gracey L; Dandona P
Int J Clin Pharmacol Res; 1988; 8(5):377-81. PubMed ID: 3229875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
